Cargando…

SARS-CoV-2 immunity and vaccine strategies in people with HIV

Current severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines, based on the ancestral Wuhan strain, were developed rapidly to meet the needs of a devastating global pandemic. People living with Human Immunodeficiency Virus (PLWH) have been designated as a priority group for SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mullender, Claire, da Costa, Kelly A S, Alrubayyi, Aljawharah, Pett, Sarah L, Peppa, Dimitra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452103/ https://www.ncbi.nlm.nih.gov/pubmed/36846557 http://dx.doi.org/10.1093/oxfimm/iqac005

Ejemplares similares

Seeing SARS-CoV-2 variants through the eyes of T cells
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy
por: Alrubayyi, Aljawharah, et al.
Publicado: (2022)

Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV Infection
por: Alrubayyi, Aljawharah, et al.
Publicado: (2020)

Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
por: Alrubayyi, Aljawharah, et al.
Publicado: (2023)

B cell persistence and evolution to SARS-CoV-2
por: Alrubayyi, Aljawharah
Publicado: (2020)

Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial Dysfunction
por: Alrubayyi, Aljawharah, et al.
Publicado: (2022)

Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV
por: Touizer, Emma, et al.
Publicado: (2021)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles
por: Touizer, Emma, et al.
Publicado: (2022)

Coordinated and sustained immune memory responses after mild COVID-19
por: Alrubayyi, Aljawharah
Publicado: (2020)

Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review
por: Richter, Felix Clemens, et al.
Publicado: (2021)

Attenuated humoral responses in HIV infection after SARS-CoV-2 vaccination are linked to global B cell defects and cellular immune profiles
por: Touizer, Emma, et al.
Publicado: (2022)

Intestinal attenuation of COVID-19 inflammation
por: Alrubayyi, Aljawharah
Publicado: (2020)

NK cells in COVID-19: protectors or opponents?
por: Alrubayyi, Aljawharah
Publicado: (2020)

Publisher Correction: NK cells in COVID-19: protectors or opponents?
por: Alrubayyi, Aljawharah
Publicado: (2020)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Entering a new era of harnessing natural killer cell responses in HIV infection
por: Peppa, Dimitra
Publicado: (2019)

Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
por: Bessen, Clara, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Investigation into the psychological impact of the COVID-19 pandemic for people living with HIV
por: Lo, Sze Wing Karina, et al.
Publicado: (2023)

Humoral response to SARS-CoV-2 vaccines in people living with HIV
por: Noe, Sebastian, et al.
Publicado: (2021)

Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV
por: Verburgh, Myrthe L., et al.
Publicado: (2023)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
por: Gupta, Ravindra Kumar, et al.
Publicado: (2020)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

503. Post-vaccination SARS-CoV-2 Infections and Immune Response in People with Immune Disorders
por: Zendt, Mackenzie, et al.
Publicado: (2023)

Natural Killer Cells in Human Immunodeficiency Virus-1 Infection: Spotlight on the Impact of Human Cytomegalovirus
por: Peppa, Dimitra
Publicado: (2017)

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
por: Yu, Haisheng, et al.
Publicado: (2023)

Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2022)

mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People
por: Garbuglia, Anna Rosa, et al.
Publicado: (2022)

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
por: Marchitto, Lorie, et al.
Publicado: (2023)

SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies
por: Beukenhorst, Anna L., et al.
Publicado: (2023)

Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus
por: Fidler, Sarah, et al.
Publicado: (2022)

Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)
por: Kim, David S., et al.
Publicado: (2020)

Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
por: Jongkees, Marlou J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gbg0hm6dm2mpl1v2rdt34fhrfe